1G3F image
Deposition Date 2000-10-24
Release Date 2001-01-10
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1G3F
Keywords:
Title:
NMR STRUCTURE OF A 9 RESIDUE PEPTIDE FROM SMAC/DIABLO COMPLEXED TO THE BIR3 DOMAIN OF XIAP
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Submitted:
1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:INHIBITOR OF APOPTOSIS PROTEIN 3
Gene (Uniprot):XIAP
Chain IDs:A
Chain Length:117
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:SMAC
Gene (Uniprot):DIABLO
Chain IDs:B
Chain Length:9
Number of Molecules:1
Biological Source:
Ligand Molecules
Primary Citation
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
Nature 408 1004 1008 (2000)
PMID: 11140637 DOI: 10.1038/35050006

Abstact

The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes. Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the IAPs and promotes caspase activation. Although undefined in the X-ray structure, the amino-terminal residues of Smac are critical for its function. To understand the structural basis for molecular recognition between Smac and the IAPs, we determined the solution structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac. The peptide binds across the third beta-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein. The complex is stabilized by four intermolecular hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions. This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small molecules that may be used for the treatment of cancers that overexpress IAPs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures